Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2024-01-23 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its Share Buyback Programme, including dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the mention of RNS/LSE/FCA confirms it is a regulatory disclosure, but the specific content points overwhelmingly to POS.
2024-01-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2024-01-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares on a specific date (18 January 2024) as part of a 'Share Buyback Programme'. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers the company buying back or selling its own shares. The presence of the RNS Number and the mention of the London Stock Exchange/FCA confirms it is a regulatory disclosure, but the specific content points precisely to POS.
2024-01-19 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (17 January 2024), including volume, highest, lowest, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The presence of the RNS Number and the mention of the FCA confirms it is a regulatory disclosure related to share capital changes, but the specific action is a share repurchase, making POS the most precise classification over the general RNS or SHA codes.
2024-01-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "PureTech Health PLC ... Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (16 January 2024), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The filing is also identified as an RNS release, which is a common channel for this type of corporate action disclosure. Therefore, the classification is POS.
2024-01-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of a 'Transaction in Own Shares' filing, which maps to the code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number (7617Z) and the date (16 January 2024) confirm it is a regulatory disclosure, but the content is highly specific to share repurchases.
2024-01-16 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.